These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9285856)
1. Pharmacotherapy of altered brain-gut interactions in functional gastrointestinal disorders. Clouse RE J Pediatr Gastroenterol Nutr; 1997; 25 Suppl 1():S18-9. PubMed ID: 9285856 [No Abstract] [Full Text] [Related]
2. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Drossman DA; Tack J; Ford AC; Szigethy E; Törnblom H; Van Oudenhove L Gastroenterology; 2018 Mar; 154(4):1140-1171.e1. PubMed ID: 29274869 [TBL] [Abstract][Full Text] [Related]
3. [Diseases of gastrointestinal motility. Treatment with motility-modifying substances]. Storr M; Allescher HD Med Monatsschr Pharm; 2003 Aug; 26(8):260-9. PubMed ID: 12953379 [No Abstract] [Full Text] [Related]
4. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders. Sanger GJ; Lee K Nat Rev Drug Discov; 2008 Mar; 7(3):241-54. PubMed ID: 18309313 [TBL] [Abstract][Full Text] [Related]
5. Ion channels as targets for treatment of gastrointestinal motility disorders. Farrugia G Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455 [No Abstract] [Full Text] [Related]
6. Tachykinin receptors as drug targets for motility disorders. Hoogerwerf WA; Sarna SK Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266 [TBL] [Abstract][Full Text] [Related]
7. Potential pharmacological approaches to management of gut motility disorders. Malagelada JR Scand J Gastroenterol Suppl; 1984; 96():111-26. PubMed ID: 6382573 [TBL] [Abstract][Full Text] [Related]
9. New vistas on gastrointestinal motility: from physiology to therapy an international symposium in Rome. Currò D; Holzer P Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():1-2. PubMed ID: 18924439 [No Abstract] [Full Text] [Related]
10. [Possibilities of electrogastrointestinography certain gastrointestinal diseases]. Rebrov VG Ter Arkh; 1981; 53(10):66-70. PubMed ID: 7313967 [No Abstract] [Full Text] [Related]
11. [Prokinetic agents (prokinetics) in the treatment of motor disorders of the gastrointestinal tract]. Frol'kis AV Ter Arkh; 1998; 70(2):69-72. PubMed ID: 9551580 [No Abstract] [Full Text] [Related]
12. Are We Close to Targeting Enteric Glia in Gastrointestinal Diseases and Motility Disorders? Gulbransen BD; Christofi FL Gastroenterology; 2018 Aug; 155(2):245-251. PubMed ID: 29964042 [No Abstract] [Full Text] [Related]
13. Overview of functional gastrointestinal disorders: dysfunction of the brain-gut axis. Mertz HR Gastroenterol Clin North Am; 2003 Jun; 32(2):463-76, v. PubMed ID: 12858602 [TBL] [Abstract][Full Text] [Related]
19. Upper gastrointestinal promotility drugs: not all uniform? Brun R; Kuo B Indian J Gastroenterol; 2009; 28(4):123-5. PubMed ID: 19937420 [No Abstract] [Full Text] [Related]
20. [Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders]. Mazur M; Furgała A; Thor PJ Folia Med Cracov; 2004; 45(1-2):33-49. PubMed ID: 16276824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]